ArticleFrontiers in pediatrics2021

Case Report: Infusion-Related Reactions to Intravenous Infliximab and Subcutaneous Ustekinumab in Pediatric Crohn's Disease.

Toshihiko Kakiuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.